Sort
64,565 grants matching “drug discovery”
Functional Dissection of CNVs in Neurodevelopmental Traits
$553,881Erica Ellen Davis · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · MH
Functional Dissection of CNVs in Neurodevelopmental Traits
$553,881Erica Ellen Davis · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · MH
Functional Dissection of CNVs in Neurodevelopmental Traits
$553,881Erica Ellen Davis · Lurie Children'S Hospital Of Chicago · R01 · FY2021 · MH
MOUSE MODELS OF GASTROINTESTINAL CANCER
$553,860University Of Cincinnati · U01 · FY2000 · CA
Optic Nerve Head SDOCT Imaging in Glaucoma
$553,852Claude F Burgoyne · Legacy Emanuel Hospital And Health Center · R01 · FY2015 · EY
Epigenetic markers of severity in nonalcoholic fatty liver disease
$553,850Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2020 · DK
Integrated approach to protein biomarker identification in Huntington Disease
$553,812Jane S Paulsen · University Of Iowa · U01 · FY2015 · NS
Delineating Functional Immunity via Image-Guided PET
$553,790Nerissa Therese Viola · Wayne State University · R37 · FY2024 · CA
Human genetics and molecular mechanisms of Vein of Galen aneurysmal malformation
$553,785Kristopher Kahle · Massachusetts General Hospital · R01 · FY2022 · NS
Divergent age-dependent peripheral innate immune response following TBI
$553,635Michelle Lee Theus · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · NS
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
$553,610Ken A Witt · Southern Illinois Univ At Edwardsville · R01 · FY2015 · AG
BETR Therapy for Herpesvirus-Associated Tumors
$553,505Martin G Pomper · Johns Hopkins University · R01 · FY2011 · CA
Targeting Kinesin Family Member 15 for the Treatment of Cancer
$553,464Andrew K Godwin · University Of Kansas Medical Center · R01 · FY2019 · CA
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
$553,433Diomedes E Logothetis · Northeastern University · R01 · FY2024 · NS
Development of biomimetic oligomers as anticoagulant antagonists
$553,390Richard W Scott · Polymedix, Inc, · R44 · FY2009 · HL
Clinical and Translational Science Center
$553,303Julianne L Imperato-McGinley · Weill Medical Coll Of Cornell Univ · KL2 · FY2013 · TR
Mechanisms of allostery and molecular recognition in efflux pumps
$553,297Nathaniel J. Traaseth · New York University · R01 · FY2024 · AI
Pharmacological Sciences Training Grant
$553,273Cynthia M. Kuhn · Duke University · T32 · FY2016 · GM
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$553,064Andre Elias Nel · University Of California Los Angeles · R01 · FY2020 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$553,064Andre Elias Nel · University Of California Los Angeles · R01 · FY2021 · CA
Simulation of learning: models and biological validation
$553,012Michel Baudry · University Of Southern California · R01 · FY2011 · NS
Cell-Based Screening for Multi-Functional Chemokine Receptor Modulators
$553,012Peter Krutzik · Primity, Inc. · R44 · FY2015 · AI
Human Brain and Spinal Fluid Resource Center
$553,003Rashed M. Nagra · Brentwood Biomedical Research Institute · R24 · FY2007 · NS
Credentialing novel cardiovascular disease genes in women by sex-specific genomic investigation of insulin resistance
$553,000Amit Majithia · University Of California, San Diego · R01 · FY2021 · HL
Microfibril deficiency in glaucoma pathogenesis
$553,000Rachel W Kuchtey · Vanderbilt University Medical Center · R01 · FY2016 · EY